Summary & Overview
HCPCS G0089: Initial Home Subcutaneous Immunotherapy/Infusion Visit
HCPCS Level II code G0089 represents professional services for an initial home visit to administer subcutaneous immunotherapy or other subcutaneous infusion drug or biological, reported in 15-minute units per calendar day. This code matters nationally as home-based administration of injectables and biologics expands care access and affects clinical workflows, care coordination, and payment policies across payers. It captures clinician time for the first in-home administration on a given day and is used where home infusion or immunotherapy services are delivered outside traditional clinical settings.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what this code represents, typical site-of-service considerations, the clinical context for subcutaneous immunotherapy and home-based biologic administration, and an outline of common modifiers and billing considerations where available. The publication also summarizes payer coverage patterns, reimbursement benchmarks, and policy updates relevant to home infusion services, as well as practical coding and billing nuances tied to initial home visit reporting.
Data not available in the input for associated taxonomies, ICD-10 diagnoses, related codes, and detailed service-line mapping is noted where applicable.
Billing Code Overview
HCPCS Level II code G0089 describes professional services for an initial visit to administer subcutaneous immunotherapy or other subcutaneous infusion drug or biological in the individual's home, billed in 15-minute increments for each infusion administration calendar day. This code covers the clinician's time for the initial home visit to provide subcutaneous medication administration.
Service Type: Home-based subcutaneous drug or biological administration (initial visit)
Typical Site of Service: Patient's home
Clinical & Coding Specifications
Clinical Context
A middle-aged patient with moderate-to-severe allergic rhinitis and venom allergy is enrolled in a home-based subcutaneous immunotherapy program after stabilization in clinic. A licensed clinician (nurse or physician assistant) conducts an initial home visit to administer the first subcutaneous immunotherapy dose of the day, perform medication verification, assess for contraindications (recent illness, uncontrolled asthma, anticoagulant changes), obtain baseline vital signs, and observe the patient for immediate adverse reactions. The visit is billed in 15-minute increments using G0089 for professional services provided in the patients home. Typical workflow: pre-visit medication reconciliation and consent, travel to the patients residence, preparation and verification of subcutaneous biological, documentation of dose and lot number, administration of the injection, 15minute observation or longer if clinically indicated, and post-visit documentation including instructions and plan for subsequent doses. Common payors for authorization and claims adjudication include Blue Cross Blue Shield, Aetna, Cigna Health, UnitedHealthcare, BUCA, and Medicare.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the professional component of a split service, if applicable for documentation-only visits separated from supply billing. |